Business · 05/03/2010Updated: 10/17/2026 · 1 min read
FDA Extends Comment Period for 510(k) Review Process
Summary
The Food and Drug Administration (FDA) is extending the comment period for its 510(k) review process until March 19, 2010, to allow interested persons more time to submit comments on the challenges associated with the process.
Original source language: Federal Register — Health and Human ServicesOpen original release →